| Description | This product is a monoclonal antibody derived from Human (Homo sapiens), which can specifically recognize Hepatitis A virus cellular receptor 2. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human |
| Affinity | KD = 23 nM, determined by surface plasmon resonance. |
| Isotype | IgG1 |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | ELISA; WB; Block; FuncS |
| Application Notes | The antibody is recommended for detection of HAVCR2 by Block, FuncS assays. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | HAVCR2 |
| Alternative Name | Hepatitis A Virus Cellular Receptor 2; T-Cell Immunoglobulin And Mucin Domain-Containing Protein 3; T-Cell Immunoglobulin Mucin Family Member 3; T-Cell Immunoglobulin Mucin Receptor 3; T-Cell Membrane Protein 3; HAVcr-2; TIMD-3; Tim-3; |
| Gene ID | 84868 |
| UniProt | Q8TDQ0 |
| Research Area | Immunology |
Figure 1 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in SDS-PAGE
SDS-PAGE analysis of V3S-0522-YC2244 in non-reduced (lane 1) and β-mercaptoethanol-reduced (lane 2) conditions. Gel stained for 30 minutes with Coomassie Blue. As a result of different β-mercaptoethanol-reduced proteins (Heavy chain and Light chain) migrate as about 50 kDa and 25 kDa, respectively. And non-reduced protein migrates as 200 kDa.
Figure 1 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in SDS-PAGE
Figure 2 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in WB
Western blot analysis of V3S-0522-YC2244 was performed by loading 2 µg onto a 12% Tris-HCl polyacrylamide gel in non-reduced (lane 1) and β-mercaptoethanol-reduced (lane 2) conditions. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least one hour. Membranes were probed with Goat Anti-Human IgG HRP secondary antibody at a dilution of 1:8,000 for 75 minutes. Chemiluminescent detection was performed.
Figure 2 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in WB
Figure 3 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in SEC-HPLC
The purity of V3S-0522-YC2244 was greater than 95% as determined by SEC-HPLC.
Column: 3 µm, 7.8 x 300 nm
Mobile phase: 150 mM Sodium Phosphate Buffer, pH 7.3
Detection: UV 280 nm
Injection: 25 µl
Figure 3 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in SEC-HPLC
Figure 4 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in WB
Western blot analysis was performed by loading 5 µg (lane 1) and 2 µg (lane 2) recombinant human HAVCR2 Protein onto a 12% Tris-HCl polyacrylamide gel. Proteins were transferred to a CN membrane and blocked with 5% skim milk for at least 1 hour. Membranes were probed with Anti-HAVCR2 Antibody (V3S-0522-YC2244) at a dilution of 1:1000 overnight at 4°C on a rocking platform. Then probed with Goat anti-Human IgG HRP secondary antibody at a dilution of 1:8,000 for one hour. Chemiluminescent was detected.
Figure 4 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in WB
Figure 5 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in ELISA
ELISA analysis of V3S-0522-YC2244 was performed by coating with recombinant human HAVCR2 Protein. Then blocked with BSA, and incubated with Anti-HAVCR2 Antibody (V3S-0522-YC2244) at a starting concentration of 2.5 µg/mL. The HRP-conjugated goat anti-human IgG as a secondary antibody. Detection was performed using TMB substrate and stopped with sulfuric acid. The absorbances were read on a spectrophotometer at 450 nm.
Figure 5 Anti-HAVCR2 Monoclonal Antibody (V3S-0522-YC2244) in ELISA
